HopeStage
Back to all studies
Not recruitingISRCTN28813846

Would genetic testing improve the diagnosis and treatment of patients with a neurodevelopmental psychiatric disorder?

Research studyAges 5–70SpainADHD
The study in practice

Understand this study

Who could participate?

Listed age limits: 5 years to 70 years.

Listed locations
Spain

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Instituto de Salud Carlos III
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Other / unclear
Locations
Spain
Age range
From 5 Years to 70 Years
Official registry ID
ISRCTN28813846
Official title
Show the full official title

Would genetic testing improve the diagnosis and treatment of patients with a neurodevelopmental psychiatric disorder?

Recruitment & locations

Not recruiting

Spain

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Instituto de Salud Carlos III.

Who can participate?

Listed age limits: 5 years to 70 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies